Evidence map›Paper›PMID 40493714›Full record

ArticleChembiochem : a European journal of chemical biology2025

α-Synuclein Sequences from Long-Lived Animals Display Generally Diminished Aggregation Compared to Shorter-Lived Animals Including Humans.

Gilbert B Ampomah, Eldon R Hard, Matthew R Pratt

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gilbert B AmpomahDepartment of Chemistry, University of Southern California, Los Angeles, California, 90089, United States.
Eldon R HardDepartment of Chemistry, University of Southern California, Los Angeles, California, 90089, United States.
Matthew R PrattDepartment of Chemistry, University of Southern California, Los Angeles, California, 90089, United States.ORCID https://orcid.org/0000-0003-3205-5615

Funding

Functional Analysis of O-GlcNAc using Synthetic Protein ChemistryR01GM114537 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PRATT, MATTHEW ROBERT · 2015 to 2024
$3.1M
NIGMS NIH HHS R01 GM114537NIGMS NIH HHS R01GM114537
6 · The paper itself

Abstract

The overall process of protein aggregation from soluble species to amyloid fibrils is toxic to neurons and can propagate along neuronal connections in ways that potentially explain the pathological progression in most neurodegenerative diseases. One of these aggregation-prone proteins is α-synuclein (α-Syn), which forms insoluble protein deposits in Parkinson's disease and other synucleinopathies. The majority of cases of Parkinson's disease occur fairly late in life, and even early-onset variants of the disease caused by mutations to α-Syn occur toward the end of the lifespan for prehistoric man. This suggests a lack of evolutionary pressure to prevent protein aggregation in animals with similar or shorter lifespans. However, α-Syn is also found in animals with notably longer lifespans. Here, this study tests the aggregation propensity of α-Syn sequences from short- and longer-lived animals at a range of evolutionary distances from humans. This study finds that, in general, longer-lived animals display slower α-Syn aggregation kinetics and the formation of smaller and less uniform fibrils. Overall, data indicate that some evolutionary pressure may have existed for preventing α-Syn aggregation, but that pressure is lost in the more recent branch of shorter-lived animals containing humans.

Indexed as

alpha-SynucleinLongevityAmino Acid SequenceAnimalsHumansKineticsProtein Aggregatesalpha-SynucleinProtein Aggregatesaggregationsamyloidsevolutionsynuclein

Identifiers

PMID40493714
PMCPMC12277024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.